pharmaphorum

MARCH 4, 2021

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. A scheme providing £500 payments to people self-isolating has been extended in England until the summer.

Vaccination 105

Vaccination Vaccine Development Life Science 105

XTalks

NOVEMBER 20, 2020

The cell-based tests are designed to identify specific T cells that are activated in response to a pathogen — which in this case would be SARS-CoV-2. Traditional antibody tests for uncovering past infections involve detection of antigen-specific antibodies produced during an immune response against a pathogen.

Antibody 98

Antibody Immune Response Protein In-Vitro 98

XTalks

NOVEMBER 15, 2023

The FDA says chikungunya is an emerging global health threat as at least 5 million cases of chikungunya virus infection have been reported in the last 15 years. According to the agency, the virus is found primarily in tropical and subtropical regions of Africa, Southeast Asia and parts of the Americas where the virus-carrying mosquitos are endemic.

FDA Approval 59

FDA Approval Vaccination Vaccine In-Vitro 59

Drug Discovery World

FEBRUARY 15, 2023

Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. A healthy immune system is naturally primed to eliminate malignant and abnormal cells through a synchronised and dynamic interplay between adaptive and innate immunity.

Research 52

Research In-Vitro In-Vivo Development 52

The Pharma Data

JANUARY 19, 2021

The year is starting off with a number of biopharma and life sciences initial public offerings (IPOs). Ortho Clinical Diagnostics is a leader in in vitro diagnostics. On January 12, its VITROS SARS-CoV-2 Antigen Test for mass-scale COVID-19 testing received FDA Emergency Use Authorization.

In-Vitro 52

In-Vitro Production Trials Manufacturing 52

XTalks

MARCH 2, 2021

In light of this, vaccine makers and regulatory bodies will need to share vaccine data and science in a clear and rigorous manner in order to clearly communicate why there is no one best vaccine, and why each authorized vaccine is a superlative tool in battling COVID-19.

Vaccination 97

Vaccination Vaccine Trials Clinical Trials 97

XTalks

APRIL 2, 2021

The highly awaited COVID-19 vaccine trial results address what have been three highly contested areas of concern: is the COVID-19 vaccine safe for kids, is it effective against some of the new variants of SARS-CoV-2 and how long will immunity last? How Safe and Effective is Pfizer’s COVID-19 Vaccine for Kids?

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59